TapImmune: Multiple Phase 2 Trials and $9M New Funding for Cancer Therapy Developer

Oct. 25, 2016
TapImmune Inc. (OTCQB: TPIV) is an immune-oncology company specializing in the development of innovative technologies for the treatment of cancer, ...

 Read More

Bloomberg TV Show

CEO Interviews

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market